- Home
- MLGO vs ANTX Comparison
MLGO vs ANTX Comparison
Compare MLGO & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLGO
- ANTX
- Stock Information
- Founded
- MLGO 2018
- ANTX 2017
- Country
- MLGO China
- ANTX United States
- Employees
- MLGO N/A
- ANTX N/A
- Industry
- MLGO EDP Services
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- MLGO Technology
- ANTX Health Care
- Exchange
- MLGO Nasdaq
- ANTX Nasdaq
- Market Cap
- MLGO 32.4M
- ANTX 37.3M
- IPO Year
- MLGO N/A
- ANTX 2022
- Fundamental
- Price
- MLGO $1.38
- ANTX $1.04
- Analyst Decision
- MLGO
- ANTX Buy
- Analyst Count
- MLGO 0
- ANTX 3
- Target Price
- MLGO N/A
- ANTX $2.00
- AVG Volume (30 Days)
- MLGO 42.2M
- ANTX 319.1K
- Earning Date
- MLGO 06-10-2025
- ANTX 05-13-2025
- Dividend Yield
- MLGO N/A
- ANTX N/A
- EPS Growth
- MLGO N/A
- ANTX N/A
- EPS
- MLGO 0.55
- ANTX N/A
- Revenue
- MLGO $74,185,505.00
- ANTX N/A
- Revenue This Year
- MLGO N/A
- ANTX N/A
- Revenue Next Year
- MLGO N/A
- ANTX N/A
- P/E Ratio
- MLGO $2.67
- ANTX N/A
- Revenue Growth
- MLGO N/A
- ANTX N/A
- 52 Week Low
- MLGO $1.11
- ANTX $0.87
- 52 Week High
- MLGO $509.60
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- MLGO 34.39
- ANTX 35.98
- Support Level
- MLGO $1.17
- ANTX $1.01
- Resistance Level
- MLGO $1.75
- ANTX $1.22
- Average True Range (ATR)
- MLGO 0.50
- ANTX 0.06
- MACD
- MLGO 0.27
- ANTX -0.01
- Stochastic Oscillator
- MLGO 9.21
- ANTX 26.09
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.